0.3198
price up icon0.76%   0.0024
 
loading
Scisparc Ltd stock is traded at $0.3198, with a volume of 230.31K. It is up +0.76% in the last 24 hours and up +4.00% over the past month. SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$0.3174
Open:
$0.3144
24h Volume:
230.31K
Relative Volume:
0.13
Market Cap:
$3.82M
Revenue:
$1.75M
Net Income/Loss:
$-5.68M
P/E Ratio:
-0.0656
EPS:
-4.8726
Net Cash Flow:
-
1W Performance:
+7.14%
1M Performance:
+4.00%
6M Performance:
+44.58%
1Y Performance:
-64.40%
1-Day Range:
Value
$0.29
$0.3222
1-Week Range:
Value
$0.29
$0.3393
52-Week Range:
Value
$0.197
$1.79

Scisparc Ltd Stock (SPRC) Company Profile

Name
Name
Scisparc Ltd
Name
Phone
-
Name
Address
-
Name
Employee
2
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SPRC's Discussions on Twitter

Compare SPRC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SPRC
Scisparc Ltd
0.3198 3.82M 1.75M -5.68M 0 -4.8726
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.94 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.12 28.51B 3.81B -644.79M -669.77M -6.24

Scisparc Ltd Stock (SPRC) Latest News

pulisher
Jun 09, 2025

SciSparc Ltd. Advances Merger with AutoMax Motors - TipRanks

Jun 09, 2025
pulisher
Jun 03, 2025

SciSparc announces publication of Japanese patent application - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Therapix Biosciences Ltd. Announces Executive Changes - marketscreener.com

Jun 03, 2025
pulisher
May 27, 2025

SciSparc Unveils Japanese Patent for Novel Pain Relief Combination - TipRanks

May 27, 2025
pulisher
May 27, 2025

SciSparc secures Japanese patent for pain relief combo By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

SciSparc Ltd. Announces Publication of Japanese Patent Application - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

SciSparc secures Japanese patent for pain relief combo - Investing.com

May 27, 2025
pulisher
May 27, 2025

SciSparc Ltd. Announces Publication of Novel Japanese Patent for Enhanced Pain Management Therapy Combining Paracetamol and PEA - Nasdaq

May 27, 2025
pulisher
May 27, 2025

SciSparc Announces Publication of Japanese Patent Application - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

SciSparc's New Pain Relief Patent Could Make Paracetamol Safer for Millions - Stock Titan

May 27, 2025
pulisher
May 21, 2025

SciSparc sets annual shareholder meeting for June 25 By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

SciSparc sets annual shareholder meeting for June 25 - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

SciSparc Ltd. Announces Annual General Meeting for June 2025 - TipRanks

May 21, 2025
pulisher
May 13, 2025

SciSparc and Clearmind Secure European Patent for Cocaine Addiction Therapy - TipRanks

May 13, 2025
pulisher
May 12, 2025

SciSparc Ltd. Announces European Patent Application for Cocaine Addiction Treatment in Collaboration with Clearmind Medicine Inc. - Nasdaq

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction - Stock Titan

May 12, 2025
pulisher
May 03, 2025

Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC) - The Globe and Mail

May 03, 2025
pulisher
May 02, 2025

SciSparc Ltd: Weathering Stock Market Storms with 3.17M Market Cap - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

A review of SPRC’s current quarter earnings predictions - uspostnews.com

May 02, 2025
pulisher
Apr 30, 2025

What's Going On With jeffs' Brands Today? - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Jeffs' Brands to Sell Smart Repair Pro Unit, SciSparc Nutraceuticals Stake to Plantify Foods; Shares Jump - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Jeffs' Brands Ltd Enters Agreement to Sell Smart Repair Pro and SciSparc Stake to Plantify Foods, Inc. for Equity Interest - Nasdaq

Apr 30, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc announces collaboration with Clearmind Medicine - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind File Patent for Eating Disorder Treatment - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire

Apr 25, 2025
pulisher
Apr 25, 2025

Novel Eating Disorder Treatment Patent Filed for 70M Patient Market | SPRC Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

3 Reasons OMI is Risky and 1 Stock to Buy Instead - The Globe and Mail

Apr 25, 2025
pulisher
Apr 18, 2025

Thinking Of Selling SciSparc Ltd (NASDAQ: SPRC) Stock? Check This Out First - Stocksregister

Apr 18, 2025
pulisher
Apr 17, 2025

SciSparc (NASDAQ:SPRC) Shares Down 6% – Here’s Why - Defense World

Apr 17, 2025
pulisher
Apr 01, 2025

SciSparc Extends Deadline for Miza III Ventures Deal - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

SciSparc Ltd. Extends Merger Agreement with AutoMax Motors - TipRanks

Apr 01, 2025
pulisher
Mar 27, 2025

SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 1,435.0% in March - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

SciSparc announces resale of 61.21M shares by selling shareholders; shares down - MSN

Mar 25, 2025
pulisher
Mar 21, 2025

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - Louisiana First News

Mar 21, 2025
pulisher
Mar 11, 2025

SciSparc and Clearmind Advance Cocaine Addiction Treatment with South Korean Patent Application - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 11, 2025
pulisher
Mar 10, 2025

Is the SciSparc Ltd (NASDAQ:SPRC) stock an investment opportunity? - US Post News

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Shares Are Soaring Monday: What's Going On? - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc announces publication of patent via Clearmind collaboration - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Ltd. and Clearmind Medicine Inc. Announce Patent Application for Combination Treatment of Cocaine Addiction - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 06, 2025

SciSparc Extends $2 Million Loan to Support Automax?s Growth Following Automax?s Entry into Direct Import of JAC Electric Vehicles - Marketscreener.com

Mar 06, 2025
pulisher
Mar 05, 2025

SciSparc Ltd. Agrees to Sell MitoCareX to N2OFF - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

SciSparc signs definitive agreement to sell MitoCareX to N2OFF - TipRanks

Mar 05, 2025
pulisher
Mar 03, 2025

SciSparc to sell MitoCareX to N2Off for $700,000 - MSN

Mar 03, 2025

Scisparc Ltd Stock (SPRC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
Cap:     |  Volume (24h):